跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Rabezo - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Rabezo
Approved
STANDARD
Rabezo
Akriti Pharmaceuticals Pvt. Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
c11eb5af1194a979
Company
Akriti Pharmaceuticals Pvt. Ltd.
Type
Standard
Approval Details
Approval Id
c11eb5af1194a979
Drug Approval Philippines Name
Rabezo
Product Name
Rabezo
Registration Number
DRP-13842
Brand Name
Rabezo
Generic Name
Rabeprazole sodium
Dosage Form
Enteric-Coated Tablet
Dosage Strength
20 mg
Manufacturer
Akriti Pharmaceuticals Pvt. Ltd.
Importer
Aglobal Care, Inc.
Distributor
Aglobal Care, Inc.
Issuance Date
28 April 2023
Expiry Date
28 April 2028
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
c11eb5af1194a979
Type
Standard
Back to Philippines FDA Approvals